EFFICACY AND SAFETY OF EARLY USE OF REDUCED TACROLIMUS IN COMBINATION WITH EVEROLIMUS VS STANDARD TACROLIMUS IN DE NOVO LIVERTRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA
被引:0
作者:
Schemmer, Peter
论文数: 0引用数: 0
h-index: 0
机构:
Hephaistos Study Grp, Hildesheim, GermanyHephaistos Study Grp, Hildesheim, Germany
Schemmer, Peter
[1
]
Braun, Felix
论文数: 0引用数: 0
h-index: 0
机构:
Hephaistos Study Grp, Hildesheim, GermanyHephaistos Study Grp, Hildesheim, Germany
Braun, Felix
[1
]
Schlitt, Hans J.
论文数: 0引用数: 0
h-index: 0
机构:
Hephaistos Study Grp, Hildesheim, GermanyHephaistos Study Grp, Hildesheim, Germany
Schlitt, Hans J.
[1
]
Pascher, Andreas
论文数: 0引用数: 0
h-index: 0
机构:
Hephaistos Study Grp, Hildesheim, GermanyHephaistos Study Grp, Hildesheim, Germany
Pascher, Andreas
[1
]
Klein, Christian-Georg
论文数: 0引用数: 0
h-index: 0
机构:
Hephaistos Study Grp, Hildesheim, GermanyHephaistos Study Grp, Hildesheim, Germany
Klein, Christian-Georg
[1
]
Neumann, Ulf
论文数: 0引用数: 0
h-index: 0
机构:
Hephaistos Study Grp, Hildesheim, GermanyHephaistos Study Grp, Hildesheim, Germany
Neumann, Ulf
[1
]
Kroeger, Irena
论文数: 0引用数: 0
h-index: 0
机构:
Novartis Pharma GmbH, Nurnberg, GermanyHephaistos Study Grp, Hildesheim, Germany
Kroeger, Irena
[2
]
Wimmer, Peter
论文数: 0引用数: 0
h-index: 0
机构:
Novartis Pharma GmbH, Nurnberg, GermanyHephaistos Study Grp, Hildesheim, Germany
Wimmer, Peter
[2
]
Nashan, Bjoern
论文数: 0引用数: 0
h-index: 0
机构:
Hephaistos Study Grp, Hildesheim, GermanyHephaistos Study Grp, Hildesheim, Germany